These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The effect of calcitonin on glucose metabolism. Blahos J; Svoboda Z; Höschl C Endokrinologie; 1976; 68(2):226-30. PubMed ID: 1009903 [TBL] [Abstract][Full Text] [Related]
4. Synthetic salmon calcitonin is not diabetogenic in patients with normal or impaired glucose metabolism. Giustina G; Cerudelli B; Cimino A; Rigosa C; Rotondi A; Radaeli E J Endocrinol Invest; 1985 Feb; 8(1):19-23. PubMed ID: 3886770 [TBL] [Abstract][Full Text] [Related]
5. The effects of calcitonin, somatostatin and hypercalcaemia on metabolic and hormonal indicators during an oral glucose tolerance test (OGTT). Zofková I; Nedvídková J; Stárka L; Zamrazil V Exp Clin Endocrinol; 1987 Mar; 89(1):91-6. PubMed ID: 2885208 [TBL] [Abstract][Full Text] [Related]
12. [Influence of vasoactive substances on blood sugar and serum insulin in normal and diabetic carbohydrate metabolism (author's transl)]. Heidrich H; Schirop T; Fichte K Med Klin; 1977 Jan; 72(3):94-101. PubMed ID: 402543 [TBL] [Abstract][Full Text] [Related]
13. A novel oral form of salmon calcitonin improves glucose homeostasis and reduces body weight in diet-induced obese rats. Feigh M; Henriksen K; Andreassen KV; Hansen C; Henriksen JE; Beck-Nielsen H; Christiansen C; Karsdal MA Diabetes Obes Metab; 2011 Oct; 13(10):911-20. PubMed ID: 21615667 [TBL] [Abstract][Full Text] [Related]
14. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus. Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051 [TBL] [Abstract][Full Text] [Related]
15. Effects of prostaglandin E1 and prostaglandin F2alpha on insulin and glucagon plasma levels during the intravenous glucose tolerance test in man. Giugliano D; Torella R; Improta L; D'Onofrio F Diabete Metab; 1978 Sep; 4(3):187-91. PubMed ID: 710679 [TBL] [Abstract][Full Text] [Related]
16. Comparison of metabolic and hormonal effects of calcitonin and somatostatin (SRIF) in the course of oral glucose tolerance test (OGTT). Zofková I; Zamrazil V Horm Metab Res; 1987 Dec; 19(12):656-60. PubMed ID: 2894341 [TBL] [Abstract][Full Text] [Related]
17. Lack of diabetogenic action of calcitonin in subjects affected by insulinoma. Passariello N; Paolisso G; Iannuzzi F; Pizza G; Marrazzo G; Sgambato S; D'Onofrio F Diabete Metab; 1989; 15(2):88-92. PubMed ID: 2544469 [TBL] [Abstract][Full Text] [Related]
18. The effect of acetylsalicylic acid on insulin response to glucose and arginine in normal man. Giugliano D; Torella R; Siniscalchi N; Improta L; D'Onofrio F Diabetologia; 1978 Jun; 14(6):359-62. PubMed ID: 669099 [TBL] [Abstract][Full Text] [Related]
19. In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. Prager R; Wallace P; Olefsky JM J Clin Invest; 1986 Aug; 78(2):472-81. PubMed ID: 3525609 [TBL] [Abstract][Full Text] [Related]
20. Metabolic effects of calcitonin in the newborn. Garel JM; Barlet JP; Kervran A Am J Physiol; 1975 Sep; 229(3):669-75. PubMed ID: 1211461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]